Gesundheitsverbund Landkreis Konstanz gGmbH — Clinical Trial Site

9 Registered trials

3 Currently recruiting

Organisation

Gesundheitsverbund Landkreis Konstanz gGmbH

Location

Singen (Hohentwiel), Germany

Identifier

ORG-100048782

Address

Virchowstrasse 10, 78224, Germany

Departments

2203: I Medizinische Klinik/ Studienzentrum
2373: I. Medizinische Klinik
Hegau-Bodensee-Klinikum Singen GmbH, Studienzentrum Hegau-Bodensee
I. Med. Klinik am Hegau-Bodensee-Klinikum
I. Medizinische Klinik am Hegau-Bodensee-Klinikum
Klinik für Urologie und Kinderurologie am Hegau-Bodensee-Klinikum Singen
Krankenhausbetriebsgesellschaft Hegau-Bodensee-Klinikum
Med. Klinik II, Gastroenterologie/Onkologie
Medizinische Klinik I Kardiologie

Clinical trials at this site (9)

Search interface

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults with Type 2 D… Pending

2024-520068-32-00 Type 2 diabetes 6
Lp(a) lowering study of pelacarsen (TQJ230) with background inclisiran in participants with elevated Lp(a) and established ASCVD Recruiting

2024-516356-18-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-02-17
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Pre-Operative Treatment in rEseCTable cOlon canceR (PROTECTOR/FIRE-10; AIO-KRK-0620; IAG-VO-0323) Prospective, randomized, open-label, multi… Recruiting

2023-508076-11-00 Colon cancer staged T3-4 and/or nodal positive by CT an 5 2025-04-01
Phase 3 study of belzutifan plus pembrolizumab as adjuvant treatment in renal cell carcinoma (RCC) Ended

2023-505023-31-00 Renal cell carcinoma 5 2023-11-17
A Study of Daily Oral Orforglipron Compared with Insulin Glargine in Participants with Type 2 Diabetes and Obesity or Overweight at Increase… Ended

2022-502833-25-00 Obesity 5 2023-08-02
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 Hypercholesterolemia 6 2022-04-08
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24